Chinese Bidders Circle Johnson & Johnson’s $4B+ Diabetes Biz

  • Post author:
  • Post category:BioPharma

Chinese interest in the J&J unit comes as the market for diabetes care in China is expected to grow rapidly.
Source: BioSpace